Cargando…
Development of camelid monoclonal nanobody against SLC39A6 zinc transporter protein
OBJECTIVE(S): SLC39A6 (solute carrier family 39) or LIV-1, is a zinc-transporter protein associated with estrogen-positive breast cancer and its metastatic spread. Significantly there is a direct relation between high zinc intake and unregulated cell proliferation and cancers. Blocking SLC39A6 prote...
Autores principales: | Ghaderi, Hajarossadat, Noormohammadi, Zahra, Habibi-Anbouhi, Mahdi, Kazemi-Lomedasht, Fatemeh, Behdani, Mahdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976899/ https://www.ncbi.nlm.nih.gov/pubmed/35432806 http://dx.doi.org/10.22038/IJBMS.2021.58542.13003 |
Ejemplares similares
-
Developing and characterizing a single-domain antibody (nanobody) against human cytotoxic T-lymphocyte-associated protein 4 (hCTLA-4)
por: Sotoudeh, Nazli, et al.
Publicado: (2021) -
Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function
por: Kazemi-Lomedasht, Fatemeh, et al.
Publicado: (2018) -
Cell-specific targeting by engineered M13 bacteriophage expressing VEGFR2 nanobody
por: Ranjibar, Farideh, et al.
Publicado: (2018) -
In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies
por: Kazemi-Lomedasht, Fatemeh, et al.
Publicado: (2017) -
Tumor Suppression by PD-1/PD-L1 Interaction Blockage in Mice Model
por: Salehi, Shima, et al.
Publicado: (2023)